Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes
Authors:
- Paaladinesh ThavendiranathanPTPaaladinesh Thavendiranathan
- Thomas H. MarwickTMThomas H. Marwick
- Svend AakhusSASvend Aakhus
- Klaus MurbræchKMKlaus Murbræch
- Richard MasseyRMRichard Massey
- Manish BansalMBManish Bansal
- Nobuaki FukudaNFNobuaki Fukuda
- Krassimira HristovaKHKrassimira Hristova
- Masaki IzumoMIMasaki Izumo
- Andre La GercheAGAndre La Gerche
- 1 August 2018
- journal article
- research article
- Published by Elsevier in JACC: Cardiovascular Imaging
- Vol. 11 (8) , 1098-1105
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Adjuvant Trastuzumab in HER2-Positive Breast CancerNew England Journal of Medicine, 2011
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated PatientsThe American Journal of Cardiology, 2011
- Cardiotoxicity of anticancer treatments: what the cardiologist needs to knowNature Reviews Cardiology, 2010
- Anthracycline-Induced CardiomyopathyJACC, 2010
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsJACC, 2009
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Journal of Clinical Oncology, 2009
- Left Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?Journal of Clinical Oncology, 2008
- Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31Journal of Clinical Oncology, 2005
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967